Industries
Dietary Supplements
Dietary supplement manufacturers operate under 21 CFR Part 111, and the most common compliance gaps involve specifications, identity testing and production records rather than facilities.
xFDA supports dietary supplement and nutraceutical manufacturers and brand owners with 21 CFR Part 111 cGMP compliance, specifications and identity testing, master and batch production records, supplier qualification, laboratory controls, audits and remediation.
How we support this sector
Where engagements typically focus
- Part 111 quality system and production record assessment
- Component identity testing and specification setting
- Master manufacturing records and batch production records
- Supplier qualification and incoming material controls
- Product complaints, returns and adverse event handling
- Labeling and claims documentation review
We help supplement manufacturers and brand owners establish oversight proportionate to the risk they carry.
When companies call us
Situations we are asked into
- A brand owner discovers it is responsible for a contract manufacturer's Part 111 compliance.
- Identity testing for botanical components is being skipped or accepted on a certificate alone.
- Master manufacturing records and batch records do not correspond.
- Specifications exist for finished product but not for components or in-process points.
- A warning letter or audit finding requires a documented remediation plan.
Commercial practice
Dietary Supplements: how we work in this sector
xFDA helps dietary supplement and nutraceutical manufacturers, brand owners and contract facilities build GMP and quality programs that meet 21 CFR Part 111 and hold up under scrutiny — component identity and supplier qualification, master and batch records, laboratory controls, CAPA and remediation, audits and training.
Part 111 GMP & quality systems
A practical quality system for a supplement operation, sized to the facility rather than copied from pharmaceutical templates.
- 21 CFR Part 111 gap assessment
- Quality unit structure, authority and release decision practice
- Master manufacturing and batch production record redesign
- Specification setting with documented rationale
- Documentation practices and record retention
Component identity & supplier qualification
The area that generates the largest share of supplement GMP findings, and the one worth fixing first.
- Ingredient risk tiering and qualification program design
- Identity testing strategy and exemption rationale files
- Supplier questionnaires, quality agreements and audits
- Certificate of analysis reliance justification
- Periodic re-evaluation and performance triggers
Laboratory controls & testing
In-house or contract laboratory data that can actually support a release decision.
- Test method suitability and validation review
- Contract laboratory qualification and oversight
- Stability program design
- OOS handling for supplement operations
- Data review and record practices
CAPA, remediation & training
Correcting an existing program, and leaving the internal team able to run it.
- Deviation and CAPA process design
- Remediation planning after a finding or a failed audit
- Facility and process compliance assessment
- Customer and third-party audit support
- Role-specific GMP training for supplement manufacturing
Typical engagements
Part 111 GMP assessment
A facility and system review against Part 111 with a prioritised finding list, risk ranking and a remediation sequence the site can actually execute.
Supplier qualification program build
Ingredient risk tiers, required evidence by tier, quality agreements and a re-evaluation cycle, implemented with the purchasing and quality teams.
Quality system build for a growing brand
For brand owners relying on contract manufacturers: the oversight, specification and release controls that make you responsible for your own product.
Dietary Supplement GMP & Compliance Assessment
Have an experienced former-FDA or industry specialist assess your GMP, quality and compliance program — component controls, records, laboratory data and release practice — and give you a plain, prioritised picture of where you stand.
Expert Answers
Dietary Supplements: answered by our consultants
- What are the most common 21 CFR Part 111 quality-system weaknesses?Incoming component identity testing that is skipped or delegated to a supplier certificate without qualification, master manufacturing records that do not match what production runs, and finished-batch release decisions made without complete specification testing.
- How should a dietary supplement manufacturer qualify its suppliers?With a written program that assigns risk by ingredient, defines what evidence is required at each risk level, and re-evaluates on a stated interval. A supplier list with certificates attached is not a qualification program.
Questions we are asked
Dietary Supplements: common questions
Direct answers from the consultants who do this work.
- Do brand owners have to comply with Part 111 if a contract manufacturer makes the product?
- Yes. Responsibility for compliance does not transfer with the manufacturing. Brand owners need documented qualification of the manufacturer, agreed specifications, review of batch documentation and a defined process for handling deviations and complaints.
- Why is component identity testing such a frequent finding?
- Because Part 111 requires at least one appropriate identity test on each incoming dietary ingredient, and supplier certificates of analysis alone do not satisfy it unless the supplier's testing has been qualified under defined conditions.
- Is 'nutraceutical' a regulatory category?
- No. It is a commercial term. FDA regulates these products primarily as dietary supplements, conventional foods or drugs depending on composition and claims — which is why claim review and product classification matter before quality systems are designed.
- What laboratory controls does a supplement manufacturer need?
- Scientifically valid methods for identity, purity, strength and composition testing, qualified instruments, documented specifications with justified acceptance criteria, and investigation practice for results that fail them.
- How do you approach supplement quality without over-engineering it?
- By scaling the system to the risk and the operation. A supplement manufacturer does not need a pharmaceutical quality manual; it needs specifications, records that reflect what was actually made, tested material and an investigation process people can follow.
Newsletter
Insights from Former FDA & Industry Experts
Practical perspectives on GMP, quality systems, validation, manufacturing and development — written by the consultants doing the work. No newsletter-only sales pitches.
Start a project
Tell us what you're working on.
Describe the product, the process or the problem. We will tell you honestly whether we are the right people to help, and who should be on the team if we are.